Survival analyses overview in hormone-refractory prostate cancer clinical trials in the prostate-specific antigen era

Clin Genitourin Cancer. 2007 Dec;5(7):420-1. doi: 10.3816/CGC.2007.n.028.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Male
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / mortality*

Substances

  • Androgen Antagonists
  • Prostate-Specific Antigen